Evicita · Supplement evidence, graded and cited · Supplements · Lifestyle · Mechanisms · Lab tests · 中文

Pro-resolving mediator precursors and active inflammation resolution (SPMs)

Pro-Resolving Mediators (SPMs) · Immune recognition and inflammatory cascade control

Acts as the biosynthetic precursor for resolvins (RvE/RvD), protectins and maresins, actively inducing neutrophil apoptosis and restoring tissue homeostasis.

Why it matters: Conventional anti-inflammatory drugs mainly suppress the start of inflammation. SPMs take part in the active wind-down of inflammation, keeping it from lingering. Human evidence is still limited on whether fish oil supplements meaningfully strengthen this pathway and bring clinical benefit.

Molecular targets: Resolvins (RvE1, RvD1), ChemR23 receptor, BLT1 antagonism, Macrophage clearance by pinocytosis

Supplements acting on this mechanism (ranked by strength and evidence)

High-potency omega-3 (EPA/DHA, SPM precursors)

★★★★☆Mechanism evidence: grade A

EPA is a precursor of E-series resolvins, and DHA is a precursor of D-series resolvins, protectins and other mediators. Both serve as metabolic substrates for inflammation-resolving mediators. Randomized human studies have detected changes in some pro-resolving lipid mediators, but these changes, and their effect on inflammation resolution, are not consistent from one mediator to another.

Krill oil (phospholipid omega-3)

★★★☆☆Mechanism evidence: grade B

EPA and DHA are precursors of pro-resolving mediators, and how much is produced depends on dose and inflammatory state. No human studies have compared whether the phospholipid form produces resolving mediators faster than other forms. The mediator changes seen in humans mostly come from studies of higher-dose n-3 fatty acids.

Open in the interactive app ›